Maryam Kavousi

Prof. Dr. Maryam Kavousi MD PhD is Professor of Population Cardiovascular Health and Principal
Investigator of Cardiometabolic Epidemiology. Her research is focused on primary prevention of
cardiovascular disease, emphasizing sex- and gender-related aspects. Her studies generate new knowledge
about population cardiovascular health with the goal of applying this knowledge to discover new biology,
inform precision cardiovascular prevention strategies, and reduce the burden of cardiovascular disease.
Prof. Dr. Kavousi is a member of the Young Academy of the Royal Netherlands Academy of Arts and
Sciences. She has received multiple (prestigious) Dutch and European research grants and awards. Prof. Dr.
Kavousi has (co)authored over 350 peer-reviewed scientific articles (H-index: 82) published in leading
scientific journals. She has (co)promoted 14 PhD students so far and currently leads a research group of 12
PhD-students, 3 Post-doctoral scientists, and 3 research and administration staff.

Research Contributions
• Complete list of publications: (https://pubmed.ncbi.nlm.nih.gov/?term=Kavousi+M%5BAuthor%5D&sort=)
Below, Five most important publications are listed:
- Kavousi M, ..., Miller CL. Multi-ancestry genome-wide study identifies effector genes and druggable pathways
for coronary artery calcification. Nature Genetics. 2023.
- Khan SS,..., Kavousi M. Coronary artery calcium score and polygenic risk score for the prediction of coronary
heart disease events. JAMA. 2023;329(20):1768-1777.
- Bos D, ... Kavousi M*, van der Lugt A*. Atherosclerotic carotid plaque composition and incident stroke and
coronary events. J Am Coll Cardiol. 2021;77(11):1426-1435. (*shared senior author)
- Kavousi M, ... Greenland P. Prevalence and prognostic implications of coronary artery calcification in low-risk
women: A meta-analysis. JAMA. 2016;316(20):2126-2134.
- Kavousi M, ... , Franco OH. Comparison of application of the ACC/AHA guidelines, ATP III guidelines, and
ESC guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311(14):1416-1423.
• Book chapters:
- Chapter: ‘Peripheral Artery Disease: An Epidemiological Perspective’. In: VAS (Vascular Independent Research
and Education European Organization) European Textbook on Vascular Medicine
- Chapter: ‘The menopause, the perimenopause and the postmenopause’. In: Dutch Textbook of Gynaecology
• Policy/Position Statements:
- Heribert Schunkert, ..., Kavousi M. Clinical utility and implementation of polygenic risk scores for predicting
cardiovascular disease. A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC
Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology. Eur Heart J. In press.
- Kavousi M, ..., Løchen ML. Electronic cigarettes and health with special focus on cardiovascular effects: position
paper of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. 2021;28(14):1552-1566.
- World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.
WHO CVD Risk Chart Working Group. Lancet Glob Health. 2019;7:e1332-e1345.
iii) Other Evidence of Impact and Contributions
• Prestigious Awards
2014: Prestigious Dutch L'Oréal-UNESCO Fellowship “For Women in Science”
2015: Prestigious VENI grant – the Netherlands Organization for Health Research and Development (ZonMw)

M. Kavousi – 2-Page Biographical Sketch – March 2025
2015: Ranked 4th place in the VIVA400 list as one of the inspiring and successful women in the Netherlands
2020: Viviane Conraads Outstanding Achievement Award – the European Society of Cardiology (ESC)
2020-2025: Member of The Young Academy of The Royal Netherlands Academy of Arts and Sciences
2023: Heart 4 Women Award
• Current Research grants
2025-2030: Leducq Foundation for Cardiovascular Research – Calcification-Omics, Molecular Elucidation, &
Therapeutics (COMET)
2023-2032: Gravity Grant Stress-in-action: Advancing the Science of Stress by Moving the Lab to Daily Life
2023-2031: Dutch Research Council – More healthy and productive years for peri-menopausal women (Menopause)
2023-2027: HORIZON 2022 EIC Pathfinder Challenge “Cardiogenomics” – B-cell related gene and protein markers
with prognostic and therapeutic value for CVD (B-specific).
2022-2026: Health Holland (EMC-TKI-LSH) (Match) Public Private Partnership – Unravelling True burden of
atrIal fibrillation across the whole spectrum; from asymptomatic pHase to critical disease (TRIUMPH)
2022-2026: Dutch Heart Foundation – HF and AF; Distinct but not too different? Similar but not the same?
2021-2026: Dutch Heart Foundation – Renal connection to microvascular disease and heart failure with preserved
ejection fraction: the next phase (RECONNEXT)
2021-2025: NIH – Trans-omic analyses of epicardial adipose tissue in atrial fibrillation
2020-2025: European Commission (IMI): – Stratification of Obese Phenotypes to Optimize Future Obesity Therapy
(SOPHIA)
2020-2025: Dutch Heart Foundation – natIonal collaborative knowledge platforM to imPact on sex- and gendeR
sEnSitive cardiovaScular medicine (IMPRESS)
2020-2025: European Research Council – Dynamic longitudinal exposome trajectories in cardiovascular and
metabolic non-communicable diseases (LONGITOOLS)
• Research fellowships
2014: Prestigious Dutch L'Oréal-UNESCO Fellowship “For Women in Science”
2019-2021: Dutch Cardiovascular Alliance “future leaders in cardiovascular field” in the Netherlands
• Journal editorships
2020-Present: Editor, Global Heart
2022-Present: Deputy Editor, Netherlands Heart Journal
2024: Present: Executive Editor, European Journal of Preventive Cardiology
• Memberships on committees, boards, or policy-making bodies
2015-2019: Member of the World Health Organization (WHO) expert committee on revising WHO Global
Cardiovascular Risk Prediction guidelines
2020-Present: Member of the European Association of Cardiology (ESC) Council on Cardiovascular Genomics
2020-2022: Scientific Advisory Board “Young at Heart”
2022-2024: Chair – Prevention, Epidemiology and Population Science Section – the European Association of
Preventive Cardiology (EAPC)
2024-Present: Chair – Prevention and Implementation Committee – EAPC
2024-Present: Member of the ESC Gender Task Force
2024-Present: Member of the ESC Data Science Committee
• Public awareness/education
2015-Present: continuous collaborations, including presentations at patient events, to improve patient awareness on
sex/gender differences in CVD – including Vrouwenhart, Topvrouwen, Harteraad, AFIP Organizations and ESC
patient forum, among others
iv) Contributions to Training and Mentorship
• Already (co)promoted 14 PhD students and currently (co)promoting 12 PhD students.
• Developing and teaching new courses including core courses in Epidemiology (‘Study Design’, ‘Markers and
Prediction Research’) and specialized courses (‘Cardiovascular Epidemiology’, ‘Selected Topics in
Epidemiology’) within Erasmus MC, Leiden University Medical Center, and University Medical Center Utrecht.
• Developing and teaching new courses on ‘Women’s Health’ and ‘Gender and Health’ within Erasmus MC,
Dutch Heart Foundation, Dutch Research Council, ESC, and EAPC.